Expert guides, hospital insights, and medical travel tips for your China health journey
Roxadustat is the first oral HIF-PHI for CKD anaemia and was first approved in China before any other major market. Here is what international patients with CKD anaemia should know.
Class A is a Chinese national hospital tier — but it doesn't tell the whole quality story. Here is how to read volume, accreditation, and outcomes data when comparing centres.
The 'International Medical Department' label is used by many Chinese hospitals — but coverage varies substantially. Here is what mature IMDs actually deliver, and what to ask before you book.
Before flying, get a written second opinion from a senior Chinese specialist via telehealth. Here is the standard 7-day workflow, what's included, and what it costs.
China is one of the few countries with operational heavy-ion therapy alongside proton therapy. Here is how the three modalities differ, where each fits clinically, and what they cost.
MASLD has become the leading cause of chronic liver disease globally. Treatment options have expanded rapidly. Here is what's available at Class A hospitals in China and how the workflow compares to Western markets.
Semaglutide and tirzepatide are revolutionising weight loss globally — but the price gap between US and Chinese hospital pharmacies is enormous. Here is what you actually get for the difference.
Chinese hospitals handled 3.19 billion outpatient visits in 2023. AI queue management, triage, and administrative automation are the tools enabling this scale — here is how they work.
China faces a severe mental health workforce shortage. AI-powered screening and chatbot support tools are being deployed at scale — here is what the published evidence actually shows about their effectiveness.
Chinese ICUs are implementing AI early warning systems that identify patients at risk of sepsis and deterioration earlier than conventional clinical assessment. Here is what the evidence shows.
China has developed six domestically approved surgical robot platforms to challenge da Vinci's dominance. Here is what the clinical evidence shows — and why cost matters for international patients.
China is digitizing pathology at scale. AI systems evaluated at Chinese cancer centers are matching specialist pathologist performance in several cancer types — with implications for diagnostic access.
PandaTouring Care Newsletter
Research-backed guides on stem cell therapy, hospital quality data, and medical travel — delivered weekly.
No spam, ever. Unsubscribe anytime.
